🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Austria / NCT05667805
Recruiting Phase 4

Coagulation in Cirrhosis

NCT05667805 · tracked via the Priya Life Science Austria tracker
Phase
Phase 4
Started
2023-01-19
Last updated
2025-01-14

Condition(s) studied

Liver Cirrhosis

Investigational drug(s) / intervention(s)

Platelet ConcentrateProthrombin Complex Concentrate →Restricitve Use

Platelet Concentrate: Liberal use (standard treatment)

Prothrombin Complex Concentrate: Liberal use (standard treatment)

Restricitve Use: Restrictive use of human prothrombin complex and platelet concentrates. No prophylactic substitution.

Study summary

Out of fear of bleeding, liver cirrhosis patients are often treated prophylactically with blood and coagulation products before minor interventions. The COUCH study will examine whether these patients benefit from a restrictive administration of coagulation products.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: Patients at the University Hospital of Vienna with diagnosed liver cirrhosis and deranged coagulation parameters (INR \>1,5 AND/ OR platelet count \<50 G/L) who are scheduled for one of the following elective invasive interventions of the liver * Biopsy or puncture * Microwave ablation (MWA) or radiofrequency ablation (RFA) * Transjugular intrahepatic portosystemic shunt (TIPS) * Percutaneous transhepatic cholangiography drain (PTCD) Exclusion Criteria: * Missing informed consent or inability to consent * Age \< 18 years * Pregnancy or breastfeeding * Manifest ascites * Chronic kidney injury stage G4 or G5, KDIGO * Uninterrupted anticoagulant therapy, except for acetylsalicylic acid (ASA) * History of bleeding or clinical signs of a hemorrhagic diathesis in the physical examination (e.g., petechia, ecchymosis, mucosal bleeding, hemorrhagic diathesis within the family, menorrhagia, prolonged bleeding after surgery)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
General Hospital of the Medical University of Vienna Vienna Austria Recruiting

More Medical University of Vienna trials in Austria

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05667805 on ClinicalTrials.gov ↗ ← All trials in Austria